Selective serotonin reuptake inhibitors in the treatment of child and adolescent depression;Inhibiteurs selectifs de la recapture de la serotonine et depression chez l'enfant et l'adolescent

Encephale

Volumn 26, Issue 3, 2000, Pages 53-60

  Condat, A ^b   Mouren Simeoni, M C ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b NONE

Author keywords

Adolescents; Children; Depression; Selective serotonin reuptake inhibitors

Indexed keywords

FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADOLESCENT; CHILD; CHILD PSYCHIATRY; CLINICAL TRIAL; DEPRESSION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDICATION; DRUG METABOLISM; DRUG TOLERABILITY; HUMAN; PSYCHOPHARMACOTHERAPY; REVIEW; FEMALE; MALE; PSYCHOLOGICAL ASPECT; RISK FACTOR; SUICIDE; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CLINICAL TRIALS; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; SUICIDE; TREATMENT OUTCOME;

EID: 0033912638     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. ALDERMAN J, WOLKOW R, CHUNG M et al. Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression : pharmacokinetics, tolerability, and efficacy. J Am Acad Child Adolesc Psychiatry 1998 ; 37 (4) : 386-94.
2. AMBROSINI P, BIANCHI M, RABINOVITCH H et al. Antidepressant treatments in children and adolescents. I. Affective disorders. J Am Acad Child Adolesc Psychiatry 1993 ; 32 : 1-6.
3. AMBROSINI PJ, DINEEN WAGNER K, BIEDERMAN J et al. Multicenter Open-Label Sertraline Study in Adolescent Outpatients with Major Depression. J Am Acad Child Adolesc Psychiatry 1999 ; 38 : 5, 566-72.
4. APTER A, RATZONI G, KING RA et al. Fluvoxamine open-label treatment of adolescent inpatient with obsessive-compulsive disorder or depression. J Am Acad Child Adolesc Psychiatry 1994 ; 33 : 342-8.
5. BOULOS C, KUTCHER S, GARDNER D et al. An open naturalistic trial of fluoxetine in adolescents and young adults with treatment resistant major depression. J Child Adolesc Psychopharmacol 1992 ; 2 : 103-11.
6. CATALANO G, COOPER DS, CATALANO MC et al. Pediatric sertraline overdose. Clin Neuropharmacol 1998 ; 21 (1) : 59-61.
7. COLLE LM, BELAIR JF, DIFERO M et al. Extended open-label fluoxetine treatment of adolescents with major depression. J Child Adolesc Psychopharmacol 1994 ; 4 : 225-32.
8. DEVANE CL. Pharmacogenetics and drug metabolism of newer antidepressant agents. J Clin Psychiatry 1999 ; 38,5 : 566-72.
9. DEVANE CL, SALLEE FR. Serotonin selective reuptake inhibitors in child and adolescent psychopharmacology : a review of published experience. J Clin Psychiatry 1996 ; 57 : 55-66.
10. EMSLIE GJ, RUSH AJ, WEINBERG WA et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997 ; 54 : 1031-37.
11. EMSLIE GJ, WALKUP JT, PLISZKA SR et al. Nontricyclic Antidepressants : Current Trends in Children and Adolescents. J Am Acad Child Adolesc Psychiatry 1999 ; 38,5 : 517-28.
12. HAZELL P, O'CONNELL D, HEATHCOAT D et al. Efficacy of tricyclic drugs in treating child and adolescent depression : A motor analysis. Br Med J 1995 ; 10 : 897-901.
13. JAIN U, BIRMAHER B, GARCIA M et al. Fluoxetine in children and adolescents with mood disorders : A chart review of efficacy and adverse effects. J Child Adolesc Psychopharmacol 1992 ; 4 : 259-61.
14. KAMINSKI CA, SANTEIRO-ROBBINS M, WEIBLEY RE. Sertraline intoxication in a child. Ann Emerg Med 1994 ; 23 : 1371-74.
15. KLEIN-SCHWARTZ V, ANDERSON B. Analysis of sertraline-only overdoses. Am J Emerg Med 1996 ; 14 : 456-8.
16. KRAMERAD, FEIGERINE RJ. Clinical effects of amitriptyline in adolescent depression. A pilot study. J Am Acad Child Adolesc Psychiatry 1981 ; 20 : 636-44.
17. KUTCHER S, BOULOS C, WARD B et al. Response to desipramine treatment in adolescent depression : a fixed dose, placebo controlled trial. J Am Acad Child Adolesc Psychiatry 1994 ; 33 : 686-94.
18. KUTCHER S. Practitioner review :the pharmacotherapy of adolescent depression. J Child Psychol Psychiatry 1997 ; 38 (7) : 755-67.
19. LAU GT, HOROWITZ BZ. Sertraline overdose. Acad Emerg Med 1996 ; 3 : 132-6.
20. LEONARD BE. The comparative pharmacological properties of selective serotonin reuptake inhibitors in animals. In : Selective Serotonin Reuptake Inhibitors, 2nd ed. West Sussex, England : Woley, 1996 : 35-62.
21. MAYERS LB, DEAN BS, KRENZELOK EP. Sertraline (Zoloft) : a pediatric overdose approach [abstract]. Veterinar Hum Toxicol 1994 ; 36 : 361.
22. McCONVILLE BJ, MINNERY KL, SORTER MT et al. An open study of the effects of sertraline on adolescent major depression. J Child Adolesc Psychopharmacol 1996 ; 6 : 41-51.
23. OGILVIE AD, BATTERSTAY S, BUBB VJ et al. Polymorphism in serotonin transports gene associated with susceptibility to major depression. Lancet 1996 ; 347 : 731-3.
24. RENAUD J, AXELSON D, BIRMAHER B. A risk-benefit assessment of pharmacotherapies for clinical depression in children and adolescents. Drug Saf 1999 ; 20 (1) : 59-75.
25. RICCI LC, WELLMEN MM. Monoamines : Biochemical Markers of Suicide ? J Clin Psychol 1990 ; 46 (1) : 106-15.
26. RIDDLE M, GELLER B, RYAN N. Another sudden death in a child treated with desipramine. J Am Acad Child Adolesc Psychiatry 1993 ; 32 : 792-7.
27. ROSENBERG DR, HOLTTUM J, GERSHON S. Textbook of Pharmacotherapy for Child and Adolescent Psychiatric Disorders. New York : Brunner/Mazel Publishers, 1994.
28. RYAN ND. The pharmacologic treatment of child and adolescent depression. Psychiatr Clin North Am 1992 ; 5 : 29-40.
29. SIMEON JG, FERGUSSON HB, DINICOLA VF et al. Adolescent depression : a placebo controlled fluoxetine treatment study and follow-up. Progr Neuropsychopharmacol Biol Psychiatry 1990 ; 14 : 791-5.
30. STROBER M. Effects of imipramine, lithium and fluoxetine in the treatment of adolescent major depression. NIMH New Clinical Drug Evaluation Unit (NCDEU) Annual Meeting, Key Biscayne, Fl, 1989, June 4-6.
31. STROBER M. The pharmacotherapy of depressive illness in adolescence. III. Diagnostic and conceptual issues in the study of tricyclic antidepressants. J Child Adolesc Psychopharmacol 1992 ; 2 : 23-9.
32. STROBER M, FREEMAN R, RIGAL J. The pharmacotherapy of depressive illness in adolescence. Psychopharmacol Bull 1990 ; 26 : 80-4.
33. TIERNEY E, JOSHI PT, LLINAS JF et al. Sertraline for major depression in children and adolescents ; Preliminary clinical experience. J Child Adolesc Psychopharmacol 1995 ; 5 : 13-27.
34. VANTALON V, GOURION D, MOUREN-SIMEONIMC. Les troubles dépressifs chez l'enfant. Etat des connaissances cliniques, épidémiologiques, et thérapeutiques. Coll Références en Psychiatrie. Paris : Doin, 1999.
35. WEISS M. Fluoxetine treatment of adolescent depression. Child Depression Consortium Meeting Toronto, Canada, 1993.